<DOC>
	<DOCNO>NCT01322854</DOCNO>
	<brief_summary>The IMRT-MC2 study prospective , two arm , multicenter , randomize phase-III-trial comparing intensity modulate radiotherapy integrate boost conventional radiotherapy consecutive boost patient breast cancer breast conserve surgery . 502 patient recruit randomized two arm : patient arm A receive IMRT 28 fraction deliver 50.4 Gy breast 64.4 Gy tumor-bed integrated boost , patient arm B receive conventional radiotherapy breast 28 fraction dose 50.4 Gy consecutive boost 8 fraction total dose 66.4 Gy . Primary aim study assessment cosmetic outcome local control breast radiotherapy . The study hypothesis intensity modulate radiotherapy ( IMRT ) , spite reduce treatment duration , least equivalent conventional therapy .</brief_summary>
	<brief_title>Adjuvant Whole Breast Radiotherapy ( RT ) With Intensity Modulated Radiotherapy ( IMRT ) Simultaneous Integrated Boost Versus Conventional RT Sequential Boost</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>All patient age &gt; 18 year &lt; 70 year breast conserve surgery . Patients age ≥ 70 year follow risk factor : Tumor stadium ≥ T2 Multifocal disease Lymphangiosis Extended intraductal component Resection margin ≤3mm Refusal patient include study Karnofsky Performance Score ≤ 70 % Metastatic disease ( M1 ) Other malignancy Previous radiotherapy breast Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>IMRT</keyword>
	<keyword>Integrated boost</keyword>
	<keyword>adjuvant radiotherapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>breast conserving surgery</keyword>
</DOC>